Recall Record

Abbott Park, IL, United States

Abbott Laboratories recalls

41 recalls recorded since 2018, most recently on 13 November 2025. 18 are listed as ongoing. Status and classification are as published by the FDA.

Recalls41
Ongoing (FDA)18
Terminated or completed23
Class I (FDA)1

Ongoing Class II Medical devices

Recall started
13 November 2025
Reason
Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.
Distribution
Worldwide distribution: US (nationwide) to states of: AK, AL, AR, AZ, CA, CO, CT, DE, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NH, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, PR; and OUS (foreign) to countries of: Al
Initiated
Voluntary: Firm initiated
Recall number
Z-0961-2026

Ongoing Class II Medical devices

Recall started
18 September 2025
Reason
Software issue for hq analyzer results in system not visibly applying appropriate flagging to results when saturation is present which may result in incorrect results.
Distribution
Worldwide distribution: US (nationwide) to states of: AL, CA, CO, FL, IN, MN, NC, NY, OK and OUS (foreign) to countries of: ALBANIA, ARGENTINA, AUSTRALIA, BANGLADESH, BELGIUM, BOSNIA AND HERZEGOVINA, BRAZIL, BULGARIA, CANADA, CAYMAN ISLANDS, CHILE, COLOMBIA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT,
Initiated
Voluntary: Firm initiated
Recall number
Z-0489-2026

Ongoing Class II Medical devices

Recall started
18 March 2025
Reason
When expired reagents are scanned or manually entered, the system will change the expiration date to current or future date without notifying user that an expired reagent is being used. Use of expired reagents is against the guidelines of the Operator's Manual.
Distribution
Worldwide distribution: US (nationwide) to the following states: AR, AZ, CA, CO, FL, GA, IA, IL, KS, LA, MA, MD, MI, MN, MO, MS, ND, NE, NJ, NV, NY, OH, OK, PA, PR, SC, TN, TX, UT, VA, WA, WI, WV, WY and OUS (foreign) to countries of: Afghanistan, Albania, Algeria, Angola, Anguilla, Argentina, Armen
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1652-2025, Z-1654-2025, Z-1655-2025, Z-1656-2025, Z-1653-2025

Ongoing Class II Medical devices

Recall started
14 June 2024
Reason
1)If Complete Blood Count with differential and reticulocyte(CBC+Diff+Retic) sample is run, then immediately following on same rack CBC+Diff sample is run, then falsely low red blood cell count may occur, generating falsely high Mean Cell Hemoglobin(MCH)/MCHC and falsely low hematocrit results. 2)Cell events may be incorrectly counted as basophil(BASO), resulting in increased BASO and %BASO counts
Distribution
Worldwide - US Nationwide distribution in the states of NY, OK, NC and the countries of ALBANIA, ARGENTINA, AUSTRALIA, BANGLADESH, BELGIUM, BOSNIA AND HERZEGOVINA, Botswana, BRAZIL, BULGARIA, CANADA, CAYMAN ISLANDS, CHILE, COLOMBIA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, FRANCE, GERMANY, GREECE,
Initiated
Voluntary: Firm initiated
Recall number
Z-2681-2024

Ongoing Class II Medical devices

Recall started
21 February 2024
Reason
The reason for the recall is the failure of calibration and quality controls due to a manufacturing issue of microparticles not meeting labeled claim. This may lead to incorrect myoglobin results and delayed diagnosis of myocardial infarction.
Distribution
Worldwide - US Nationwide distribution in the states of AL, AR, AZ, CA, FL, GA, IL, KS, LA, MI, MO, MS, NE, NY, OH, OR, PA, TX, VA, and WI. The countries of Angola, Austria, Belarus, Belgium, Brazil, Czech Republic, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Latvia, Lithuania,
Initiated
Voluntary: Firm initiated
Recall number
Z-1476-2024

Terminated Class II Food

Recall started
31 October 2023
Terminated
3 September 2024
Reason
Marketed towards preterm infants without approval as a new drug or licensed biologic, as well as unsafe food additive
Distribution
Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Jersey, New Mexico, Nevada, New York,
Initiated
Voluntary: Firm initiated
Recall number
F-0328-2024

Ongoing Class II Medical devices

Recall started
19 October 2023
Reason
The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).
Distribution
Distribution was made to AL, AR, AZ, CA, CO, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY, including Puerto Rico. There was also government and military distribution. Foreign distribution was made to Brazil.
Initiated
Voluntary: Firm initiated
Recall number
Z-0604-2024

Ongoing Class II Medical devices

Recall started
19 October 2023
Reason
The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).
Distribution
U.S.: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV O.U.S.: Brazil
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0680-2024, Z-0681-2024, Z-0682-2024

Ongoing Class II Medical devices

Recall started
30 May 2023
Reason
There are potential performance issues found in the Alinity ci-series System software versions 3.4.0 and lower, including: 1) SCC Reagent load error during daily maintenance; 2) Sample Laboratory Report error; 3) Customer requests mechanism to prevent user error when creating new lots of value assigned Calibrators; 4) Error in processing tests after CCCintController encountered an error with the assay information downloaded from SCC; 5) The assay editor does not correctly check sample dilution total volume limits; 6) User-Applied Labels not adhering to Reagent Bottles; 7) ICT Module did not expire after warranty was exceeded. These performance issues could lead to erroneous results for multiple analytes.
Distribution
US: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV OUS: ALBANIA, ALGERIA, ARGENTINA, AUSTRALIA, AUSTRIA, BAHAMAS, BAHRAIN, BANGLADESH, BELARUS, BELGIUM, BERMUDA,
Initiated
Voluntary: Firm initiated
Recall number
Z-0613-2024

Terminated Class II Food

Recall started
28 March 2023
Terminated
14 December 2023
Reason
Potential of foreign material (hard plastic) within product
Distribution
AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, NC, NE, NJ, NV, NY, OH, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV
Initiated
Voluntary: Firm initiated
Recall number
F-0698-2023

Ongoing Class III Medical devices

Recall started
24 November 2022
Reason
Reaction vessels may contain a potential contaminant that could affect their optical performance.
Distribution
US Distribution: IL, MN, MO, NC, ND, NJ, NY, OK, SC, TX, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-0958-2023

Terminated Class II Food

Recall started
13 October 2022
Terminated
14 August 2024
Reason
Compromised seal integrity which could lead to spoilage
Distribution
Domestic: Alaska, Alabama, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maine, Maryland, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Ham
Initiated
Voluntary: Firm initiated
Recall numbers
F-0156-2023, F-0160-2023, F-0158-2023, F-0157-2023, F-0161-2023, F-0159-2023, F-0165-2023, F-0162-2023, F-0164-2023, F-0155-2023, F-0154-2023, F-0163-2023

Ongoing Class II Medical devices

Recall started
26 July 2022
Reason
One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1660-2022

Terminated Class II Food

Recall started
3 July 2022
Terminated
9 June 2023
Reason
Potential leaking/pinholes in bottle
Distribution
Distributed to consignees in MD, NY, AL, FL, MA, NJ, and MI
Initiated
Voluntary: Firm initiated
Recall number
F-1575-2022

Ongoing Class II Medical devices

Recall started
9 June 2022
Reason
There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Distribution
US: AK AL AR AZ CA CO CT FL GA IA ID IL IN KS KY LA MA MD MI MN MO MS MT NC ND NE NJ NV NY OH OK OR PA PR SC SD TN TX UT VA WA WI WV OUS: ALBANIA ALGERIA ANDORRA ANGOLA ARGENTINA ARMENIA AUSTRALIA AUSTRIA AZERBAIJAN BAHAMAS BANGLADESH BELARUS BELGIUM BERMUDA BOSNIA AND HERZEGOVI BRAZIL BRUNEI BULGA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1456-2022, Z-1454-2022, Z-1455-2022

Terminated Class III Food

Recall started
3 June 2022
Terminated
21 December 2022
Reason
The third party contract manufacturer used a dextrose ingredient derived from wheat in one lot of the Strawberry Lemonade powder, which is not declared on the label.
Distribution
AZ, CA, FL, GA, IL, IN, MN, NC, NY, OH, KS, and TN.
Initiated
Voluntary: Firm initiated
Recall number
F-1312-2022

Terminated Class II Food

Recall started
3 June 2022
Terminated
14 April 2023
Reason
These products are being recalled due to the potential of leakage from the 1L container.
Distribution
AL, AR, AZ, CA, CO, DE, FL, GA, IA, IL, IN, KS, KY, LA, MI, MO, MS, NC, NH, NY, OH, OR, PA, TN, TX, UT, VA and WI
Initiated
Voluntary: Firm initiated
Recall numbers
F-1343-2022, F-1344-2022

Ongoing Class II Medical devices

Recall started
8 March 2022
Reason
This calibrator lot did not meet acceptance criteria during ongoing stability testing. When a calibration is performed with this lot, controls may exceed the specified range in the Instructions for Use (IFU).
Distribution
Worldwide Distribution: US (nationwide) and OUS (foreign) including countries of: AUSTRIA, BELGIUM, BOSNIA AND HERZEGOVI, CROATIA, CYPRUS, CZECH REPUBLIC, DENMARK, FRANCE, GERMANY, GREECE, IRAQ, ITALY, KAZAKHSTAN, LITHUANIA, LUXEMBOURG, MACEDONIA, MOROCCO, PANAMA, PORTUGAL, QATAR, ROMANIA, SAUDI ARA
Initiated
Voluntary: Firm initiated
Recall number
Z-0891-2022

Ongoing Class I Food

Recall started
17 February 2022
Reason
Consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants and evidence of Cronobacter sakazakii in the manufacturing facility where the product had been produced
Distribution
US Nationwide. Worldwide.
Initiated
Voluntary: Firm initiated
Recall numbers
F-0935-2022, F-0936-2022, F-0922-2022, F-0932-2022, F-0923-2022, F-0919-2022, F-0941-2022, F-0945-2022, F-0937-2022, F-0938-2022, F-0956-2022, F-0925-2022 and 29 more

Ongoing Class II Medical devices

Recall started
3 February 2022
Reason
Software error associated with the immunoassay analyzer wash cycle which is using 1 mL of wash buffer instead of the intended 3 mL of wash buffer to wash the exterior of the probe.
Distribution
Worldwide distribution: US (nationwide) including states of: AL, CA, GA, IL, IN, MN, MO, NC, OK, PA, RI, SC, TN, TX, WA, WI, MD and countries (OUS) including of: Australia, Austria, Bahrain, Belgium, Brazil, china, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Germany, Greece, Hong Kong, Hungary
Initiated
Voluntary: Firm initiated
Recall number
Z-0749-2022

Ongoing Class II Medical devices

Recall started
29 September 2021
Reason
Twelve software-related issues affecting software version 9.41 and earlier were identified. The issues include bypassing error codes, incorrect calibration, loss of module communication leading to overfilling wash buffer containers, missing QC flags, signal spikes, abnormal optics reads, and incorrect sample aspiration. The issues may lead to inaccurate results with an unknown bias direction and magnitude for assays measuring cardiac, metabolic (including diabetes), toxicology, prenatal, therapeutic drug monitoring, infectious disease, oncology, hepatic, pancreatic, hematological, endocrinologic, inflammatory analytes.
Distribution
U.S.: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV. O.U.S.: AFGHANISTAN ALBANIA, ALGERIA, ANDORRA, ANGOLA, ARGENTINA, ARMENIA, AUSTR
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0271-2022, Z-0272-2022

Ongoing Class II Medical devices

Recall started
26 July 2021
Reason
Due to potential performance issues with software version 3.2.3 and earlier. Performance issues are: 1) There is the potential for onboard reagents past their lot expiration date or onboard stability time to be incorrectly displayed on the Reagent Status screen with a status of "OK". In this scenario, the expired reagent will remain in the carousel for sample processing. 2) Performing monthly maintenance procedure 5701 Clean ICT Drain Tip incorrectly may potentially cause issues such as damaged connector or leaking connection. 3) A sample exception with message code 150 "Unable to process test. Previous processing module error" is produced without notifying the operator of a reagent pipettor failure and may cause processing module to transition into the Pausing state. Tests initiated prior to the sample exception may continue to process without dispense of reagents, potentially leading to incorrect results. 4. Reagent short dispense: Alinity c needs a control measure to protect against the potential for short reagent dispense. Addition of a maximum depth limit for reagent cartridges on the Alinity c to prevent the potential for a short dispense is needed. 5. RSM indicators were blinking green incorrectly: The Reagent and Sample Manager (RSM) indicators will incorrectly blink green indicating that processing is completed and the rack or cartridge can be removed from the loading area when the rack or cartridge should not be accessed. 6. Erroneous ICT Calibration Curves: Erroneous ICT calibration curves might be generated for the Alinity c when there is a malfunction of ICT reference solution delivery, use of wrong/evaporated calibrator, defective ICT modules, etc.
Distribution
Worldwide distribution. US nationwide including Puerto Rico; Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Bermuda, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmar
Initiated
Voluntary: Firm initiated
Recall number
Z-2472-2021

Ongoing Class II Medical devices

Recall started
12 July 2021
Reason
A design defect (hardware and software) allows liquid waste pressure to build up and potentially spray users/operators.
Distribution
Worldwide distribution. US nationwide, Australia, Bahrain, Belgium, Brazil, China, Colombia, Croatia, Egypt, Germany, Greece, Hong Kong, Hungary, Iran, Ireland, Israel, Italy, Jordan, Kuwait, Mexico, Netherlands, Pakistan, Poland, Portugal, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Tanzan
Initiated
Voluntary: Firm initiated
Recall number
Z-2276-2021

Ongoing Class II Medical devices

Recall started
10 June 2021
Reason
There is a potential for >10% under-recovery on Activated Alanine Aminotransferase (A-ALT) samples greater than 1,200 U/L. In addition there is a potential for a >10% shift in patient results with samples containing bilirubin concentrations greater that 31 mg/dL. This could lead to incorrect patient results
Distribution
Worldwide distribution - US Nationwide distribution in the states of VA, UT, TX, TN, SD,PA, NY, ME, ID, CA and the countries of AFGHANISTAN, AUSTRALIA, AUSTRIA, BAHAMAS, BANGLADESH, BELGIUM, BOSNIA AND HERZEGOVI, CANADA, CAYMAN ISLANDS, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, FAROE ISLAND, FINLAND,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2187-2021, Z-2184-2021, Z-2186-2021, Z-2185-2021

Terminated Class II Medical devices

Recall started
2 April 2020
Terminated
28 April 2021
Reason
In the case of an AQM clot detection error a portion of the distilled water from the Aliquoter Module hydraulic circuit may be dispensed into the Primary Tube leading to sample dilution, which could lead to incorrect results.
Distribution
Worldwide distribution - U.S. Nationwide distribution including in the states of NC, ND, SC, TN. The countries of United Kingdom, France, New Zealand, Pakistan, Turkey.
Initiated
Voluntary: Firm initiated
Recall number
Z-2251-2020

Terminated Class III Medical devices

Recall started
1 April 2020
Terminated
1 September 2020
Reason
Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.
Distribution
International distributed only in Mexico, no US distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1894-2020, Z-1893-2020, Z-1895-2020

Terminated Class II Food

Recall started
13 September 2019
Terminated
30 April 2020
Reason
Off color and odor. Compromised can seam due to product (powder) in the seam, this poor seal potentially allowed air into the container.
Distribution
Nationwide in the US. Canada and Malaysia.
Initiated
FDA Mandated
Recall number
F-0022-2020

Terminated Class III Medical devices

Recall started
24 May 2019
Terminated
1 April 2021
Reason
Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing.
Distribution
Worldwide Distribution - US Nationwide in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. Distributed worldwide to ALGERIA, ANDORRA, AUSTRI
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2078-2019, Z-2079-2019

Terminated Class II Medical devices

Recall started
22 May 2019
Terminated
22 January 2021
Reason
Calibrator level 2 bottle may have been manufactured incorrectly for a portion of the lot. The manufacturer observed no impact to assay performance between the HbA1c concentration range of 5.33% to 6.87%. However, outside of this range, a bias of greater than 3% may be seen with patient results. The device failure that is associated with this recall can result in potentially negatively and positively biased patient test results for HbA1c. The firm is investigating the root cause.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AR, AZ, CA, FKL GA, IA, ID, IL, IN, KS, LA, MN, MO, NC, NE, NJ, NV, NY, OH, OK, PA, SC, SD, TX, UT, VA, and WI; and countries of Austria, Germany, Italy, South Africa, and Spain.
Initiated
Voluntary: Firm initiated
Recall number
Z-1688-2020

Terminated Class II Medical devices

Recall started
9 May 2019
Terminated
7 October 2020
Reason
The diluent tubing used on the instrument appears cloudy or to have a powder/film on the inner and outer surfaces which may result in falsely elevated platelet results.
Distribution
Distribution was made to GA, LA, MA, NC, NY, SC, and TX. There was no military/government distribution. Foreign distribution was made to Australia, Germany, Greece, Honduras, Indonesia, Italy, and Serbia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0173-2020

Terminated Class II Medical devices

Recall started
1 May 2019
Terminated
2 July 2021
Reason
Mixer blade may separate from mixer due to the screw and nut failure and detachment. As a result of the mixer blade missing, the sample and reagent are inadequately mixed.
Distribution
Worldwide distribution  US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, ME, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, Puerto Rico and St. Croix US Virgin Islands. Countries of A
Initiated
Voluntary: Firm initiated
Recall number
Z-1671-2020

Terminated Class III Medical devices

Recall started
9 April 2019
Terminated
20 December 2019
Reason
Devices were delivered without the required dry ice.
Distribution
Distribution to Latvia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1358-2019, Z-1360-2019, Z-1361-2019, Z-1363-2019, Z-1359-2019, Z-1362-2019, Z-1356-2019, Z-1355-2019, Z-1357-2019

Terminated Class II Medical devices

Recall started
20 February 2019
Terminated
13 August 2021
Reason
There is a potential for the device to generate Quality Control (QC) low or out-of-range low for parameters RBC and PLT.
Distribution
Worldwide Distribution: US (nationwide) including Puerto Rico, and countries of: Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Belize, Bermuda, Bosnia and Herzegovina, Brazil, Bulgaria, Burkina Faso, Cameroon, Canada, Chile, China, Colombia, Co
Initiated
Voluntary: Firm initiated
Recall number
Z-1074-2019

Terminated Class II Medical devices

Recall started
2 January 2019
Terminated
30 June 2021
Reason
Abbott internal testing has identified that the Magnesium urine application demonstrates depressed urine result recovery. All samples >0.5mEq/L fail the linearity acceptance criteria for the bias specification and demonstrate depressed recovery of up to 37%. The specific cause of the negative bias/depressed results is currently under investigation.
Distribution
Worldwide Distribution: US (nationwide) and to countries of: CHINA, THAILAND, GUATEMALA, and EL SALVADOR.
Initiated
Voluntary: Firm initiated
Recall number
Z-0971-2019

Terminated Class II Medical devices

Recall started
7 September 2018
Terminated
2 February 2021
Reason
The firm identified customer sites where modules which the safety pacemaker label is missing. Information regarding the label included in the Operations Manual has been updated to specify: 1) the risk of malfunction applies to anyone with a pacemaker who may work on these modules; 2) the minimum safety distance has increased to 200 mm (7.87") from transport mechanisms. Any person with a pacemaker must not get closer than this distance from modules axes.
Distribution
US: TX, VA, AZ, NV, MA, LA, MN, PA, SC, NJ, NY, CA, IL, IN, WA, FL, TN, PA, KS, ND, NC, CT OUS: Argentina, Australia, Belgium, Canada, China, Denmark, France, Greece, Hong Kong, Ireland, Italy, New Zealand, Norway, Oman, Pakistan, Philippines, Portugal, Russia, Saudi Arabia, Singapore, Spain, Tai
Initiated
Voluntary: Firm initiated
Recall number
Z-2755-2019

Terminated Class II Medical devices

Recall started
28 August 2018
Terminated
23 September 2020
Reason
There is a potential to generate falsely elevated serum or plasma chloride results when using the product.
Distribution
Worldwide Distribution - US Nationwide in the states of AR, CA, CT, FL, IA, IN, LA, MA, MD, MS, NJ, NY, PA, SC, TX, VT, WA, and WV. There was government distribution and no military distribution. Foreign distribution was made to Australia, China, Hong Kong, and New Zealand.
Initiated
Voluntary: Firm initiated
Recall number
Z-1296-2019

Terminated Class II Medical devices

Recall started
18 July 2018
Terminated
13 August 2020
Reason
The product has a stability issue which may lead to an error code indicating "Unable to calculate result, reaction check failure" and/or Quality Control results out of range low.
Distribution
Distribution was made nationwide, including Puerto Rico. There was also government and military distribution. Foreign distribution was made to Algeria, Argentina, Australia, Austria, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Cayman Islands, Chile, China
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1076-2019, Z-1075-2019

Terminated Class II Medical devices

Recall started
17 July 2018
Terminated
23 September 2020
Reason
There is a potential to generate incorrect results on the instrument if particular error codes are not resolved before transitioning to the Running status.
Distribution
Worldwide distribution - US Nationwide and countries Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bangladesh, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Burkina FASO, Canada, Cayman Islands, Chile, China, Colomb
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1102-2019, Z-1104-2019, Z-1103-2019

Terminated Class II Medical devices

Recall started
14 June 2018
Terminated
8 September 2021
Reason
Abbott is advising customers that a small number of CardioMEMS(R) Hospital Electronics Systems (Model CM3000) and Patient Electronics Systems (Model CM1100) may deliver a system error, known as Error 5. While this error message is intended to present if the electronics system exceeds a certain temperature, these units may deliver a false Error 5 message due to an incorrectly configured component within the device electronics.
Distribution
US, Canada, Netherlands, Germany, Great Britain, France, Ireland, Belgium
Initiated
Voluntary: Firm initiated
Recall number
Z-2522-2018

Terminated Class II Medical devices

Recall started
16 May 2018
Terminated
16 August 2021
Reason
An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products.
Distribution
Distribution was nationwide, including Puerto Rico. There was government/military distribution. Foreign distribution was made to Canada, Albania, Algeria, Andorra, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovi, Botswana, Brazil, B
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1992-2019, Z-1990-2019, Z-1991-2019, Z-1988-2019, Z-1989-2019, Z-1994-2019, Z-1995-2019, Z-1987-2019, Z-1993-2019

Terminated Class II Medical devices

Recall started
8 December 2017
Terminated
11 July 2019
Reason
There is a potential to generate falsely depressed patient results in the cuvettes adjacent to the detached segment post for any assay run on the c4000, c8000, and c16000 instrument.
Distribution
Worldwide Distribution: US (nationwide) including Puerto Rico and countries of: Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Burkina Faso, Cameroon, Canada, Cayman
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0922-2018, Z-0921-2018, Z-0923-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.